V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240008422 | 240016016 | 1.58 | 81.7 | Palliative (P) | 2014-02-16 | 2014-02-25 | Cisplatin + Etoposide (3 day) | 02 | N | 240010622 | PACLITAXEL |
| 240008423 | 240005151 | 1.62 | 83 | Palliative (P) | 2016-09-02 | 2016-09-11 | DA-EPOCH-R | Y | N | 240010691 | METHOTREXATE |
| 240008424 | 240005151 | 1.51 | 49.4 | Palliative (P) | 2015-10-01 | 2015-10-01 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | N | 240010691 | ABVD |
| 240008425 | 240005152 | 1.79 | 79.6 | Curative (C) | 2015-02-15 | 2015-02-17 | Cytarabine High Dose | 02 | N | 240010862 | ECF |
| 240008426 | 240010849 | 1.83 | 87 | null | 2016-11-09 | 2016-11-20 | HD EuroNet-PHL-C1 OEPA | N | null | 240010898 | RCEOP |
| 240008427 | 240005153 | 1.63 | 103 | Curative (C) | 2015-12-29 | 2016-01-05 | EP | 02 | 2 | 240010904 | CISPLATIN + FLUOROURACIL + RT |
| 240008428 | 240010850 | 1.61 | 61 | null | 2017-05-03 | 2017-05-08 | Mitoxantrone | N | N | 240010918 | AML16 TRIAL |
| 240008429 | 240005154 | 1.58 | null | Curative (C) | 2018-07-17 | 2018-07-17 | Cisplatin + Etoposide (3 day) | 2 | N | 240010921 | R-EPOCH |
| 240008430 | 240005155 | 1.7 | 61.5 | Curative (C) | 2016-11-13 | 2016-11-18 | CYCLOPHOSPHAMIDE + RITUXIMAB | N | N | 240010938 | BRENTUXIMAB |
| 240008431 | 240005156 | 155 | 63.85 | Palliative (P) | 2016-10-29 | 2016-09-21 | BLEOMYCIN + CISPLATIN + MITOMYCIN | Y | N | 240011020 | SUNITINIB |
| 240008432 | 240005157 | 1.6 | 62.8 | Curative (C) | 2015-11-06 | 2015-11-09 | Cetuximab 7 day (Cycle 1) | null | N | 240011026 | CISPLATIN + FLUOROURACIL + RT |
| 240008433 | 240005158 | 1.66 | 92.6 | null | 2016-02-07 | 2016-03-11 | Bevacizumab 15mg/kg | N | null | 240011050 | CARBOPLATIN + DOXORUBICIN |
| 240008434 | 240005158 | 1.8 | 82.6 | Neo-adjuvant (N) | 2015-01-14 | 2015-01-26 | Vincristine (weekly) | 2 | N | 240011050 | CVP |
| 240008435 | 240005159 | 1.8 | 120.4 | Palliative (P) | 2014-05-27 | 2014-05-31 | BEAM | 02 | N | 240011070 | CVP |
| 240008436 | 240005159 | 1.83 | 97.4 | Palliative (P) | 2018-06-17 | 2018-06-29 | ABVD | 02 | N | 240011070 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 240008437 | 240013614 | 1.46 | 55.4 | null | null | 2016-06-24 | AML 18 TRIAL | null | null | 240011154 | CISPLATIN + ETOPOSIDE |
| 240008438 | 240005160 | 1.53 | 67.7 | null | 2016-11-12 | 2016-11-12 | CISPLATIN + ETOPOSIDE | 2 | N | 240011155 | mEOC TRIAL |
| 240008439 | 240010853 | 1.74 | 53 | Curative (C) | null | 2018-05-18 | Docetaxel + Gemcitabine with GCSF | 01 | null | 240011159 | CISPLATIN + TOPOTECAN |
| 240008440 | 240005161 | 1.68 | 99.2 | Palliative (P) | 2017-08-07 | 2017-08-09 | RAVVA TRIAL | N | N | 240011182 | BORTEZOMIB |
| 240008441 | 240010854 | 1.76 | 0 | Curative (C) | 2014-12-07 | 2014-12-11 | CHOEP | N | N | 240011194 | R CODOX M |
| 240008442 | 240005162 | 1.64 | 48 | Palliative (P) | 2013-09-16 | 2013-09-16 | VAC | 02 | N | 240011208 | CISPLATIN + FLUOROURACIL |
| 240008443 | 240005163 | 1.79 | 72 | Palliative (P) | 2015-09-09 | 2015-09-10 | Thalidomide 50mg | 02 | N | 240011215 | AML17 TRIAL |
| 240008444 | 240005164 | 1.62 | 54 | Disease modification (D) | null | 2017-01-12 | MABCUTE TRIAL | 1 | N | 240011315 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE |
| 240008445 | 240005165 | 1.55 | 53.3 | Curative (C) | 2016-10-19 | 2016-10-25 | mEOC TRIAL | 02 | N | 240011368 | CAPECITABINE |
| 240008446 | 240005166 | 1.61 | 68.5 | Curative (C) | 2014-08-27 | 2014-09-03 | ECX | N | N | 240011381 | ABVD |
| 240008447 | 240005166 | 0 | 56.7 | Curative (C) | null | 2015-02-27 | FEC 100 | N | N | 240011381 | CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE + RITUXIMAB |
| 240008448 | 240005167 | 0 | 55.8 | Palliative (P) | 2018-01-29 | 2018-01-29 | CISPLATIN + FLUOROURACIL | 02 | N | 240011479 | BEVACIZUMAB + CISPLATIN + PACLITAXEL |
| 240008449 | 240010856 | 1.7 | 80.7 | Palliative (P) | 2014-07-23 | 2014-07-24 | CODOX M | N | N | 240011485 | CTD |
| 240008450 | 240005168 | 1.48 | 52.6 | Curative (C) | 2018-05-26 | 2018-06-01 | Bortezomib + CYCLOPHOSPHAMIDE | N | N | 240011523 | CISPLATIN + TOPOTECAN |
| 240008451 | 240005169 | 1.55 | 66.6 | Curative (C) | 2018-01-23 | 2018-02-11 | Trastuzumab Subcutaneous | 2 | N | 240011575 | IVA |
| 240008452 | 240005170 | 1.66 | 102.2 | Curative (C) | 2015-12-20 | 2015-12-28 | Pazopanib | 2 | null | 240011596 | CYTARABINE + METHOTREXATE + RITUXIMAB + THIOTEPA |
| 240008453 | 240005171 | 1.7 | 59.6 | Palliative (P) | 2013-12-20 | 2013-12-24 | CYCLO + RITUXIMAB + VINCRISTINE | N | N | 240011615 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 240008454 | 240005172 | 1.78 | 89 | Palliative (P) | 2016-12-07 | 2016-12-08 | Cytarabine Low Dose | 1 | N | 240011643 | MPV |
| 240008455 | 240005173 | 1.76 | 97.04 | Curative (C) | 2019-01-01 | 2019-01-07 | BORTEZOMIB + DOXORUBICIN | 2 | N | 240011654 | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE |
| 240008456 | 240005173 | 1.57 | 89 | Palliative (P) | 2015-07-20 | 2015-07-31 | CYCLOPHOSPHAMIDE + FLUDARABINE | N | N | 240011654 | OXALIPLATIN + MDG |
| 240008457 | 240005174 | 1.76 | 73.9 | Palliative (P) | 2017-01-16 | 2017-01-18 | BORTEZOMIB + THALIDOMIDE | N | N | 240011695 | DHAP |
| 240008458 | 240005174 | 1.69 | 51.2 | Curative (C) | 2016-06-04 | 2016-07-14 | Cytarabine Low Dose | N | N | 240011695 | VEPEMB |
| 240008459 | 240005175 | 1.52 | null | Not known (9) | 2016-10-15 | 2016-10-19 | ECX | 02 | N | 240011739 | BEVACIZUMAB |
| 240008460 | 240005176 | null | 70.2 | null | 2016-07-02 | 2016-08-11 | NORDIC | null | N | 240011773 | BORTEZOMIB + THALIDOMIDE |
| 240008461 | 240005177 | null | 47.5 | Curative (C) | 2015-04-17 | 2015-04-24 | PEMBROLIZUMAB | N | N | 240011779 | NHL 2003 |
| 240008462 | 240005178 | 1.65 | null | null | 2018-08-28 | 2018-08-30 | Carboplatin + Doxorubicin | N | N | 240011790 | CISPLATIN + FLUOROURACIL |
| 240008463 | 240005179 | 1.8 | 57.9 | Curative (C) | 2015-09-29 | 2015-09-29 | IBRUTINIB | 2 | N | 240011844 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 240008464 | 240005180 | null | 89 | Disease modification (D) | 2017-07-20 | 2017-08-16 | Cisplatin + Paclitaxel | null | N | 240011904 | PACLITAXEL |
| 240008465 | 240005180 | 1.66 | 58.1 | Disease modification (D) | 2017-11-13 | 2017-11-13 | Cisplatin + Etoposide (3 day) | N | N | 240011904 | IMATINIB |
| 240008466 | 240005181 | 1.54 | 80 | Curative (C) | null | 2017-07-30 | CISPLATIN + FLUOROURACIL + RT | 1 | null | 240012046 | GEMCARBO |
| 240008467 | 240005182 | 1.55 | null | null | 2014-09-03 | 2014-09-18 | CISPLATIN + FLUOROURACIL | 2 | null | 240012059 | CISPLATIN + ETOPOSIDE |
| 240008468 | 240005182 | 2.04 | 56 | Disease modification (D) | 2014-07-03 | 2014-07-08 | Bortezomib +/- Dexamethasone | 2 | N | 240012059 | CYCLOPHOSPHAMIDE + ETOPOSIDE + PROCARBAZINE |
| 240008469 | 240005183 | 1.63 | 91.8 | Disease modification (D) | 2017-04-01 | 2017-04-05 | AML 19 TRIAL | 2 | N | 240012087 | VEDEX |
| 240008470 | 240005183 | 1.73 | 87 | Curative (C) | 2012-11-24 | 2012-11-24 | Gemcitabine + Oxaliplatin | N | null | 240012087 | FCR |
| 240008471 | 240013615 | null | 69.7 | Not known (9) | 2017-10-18 | 2017-10-31 | AML 19 TRIAL | N | N | 240012140 | CODOX M |